# CENCORA, INC. (COR) FY2025 YTD Q3 P&L / Income Statement

- Company: CENCORA, INC. (COR)
- Period: 2024-10-01 to 2025-06-30
- Filing: Q3 FY2025 10-Q, filed 2025-08-06, accession number 0001140859-25-000122
- Page: https://plicit.ai/financials/cor/fy2025-ytd-q3-income-statement
- Chart image: https://plicit.ai/charts/cor-fy2025-ytd-q3-income-statement-sankey.png

## Chart details: Revenue by Business Segment

Income statement for 2024-10-01 through 2025-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 237,604,265,000 US dollars
- **Cost of goods sold**: 229,079,303,000 US dollars
- **Gross profit**: 8,524,962,000 US dollars
- **Operating expenses (calculated)**: 5,914,864,000 US dollars
- **Operating income**: 2,610,098,000 US dollars
- **Other income (expense), net (calculated)**: negative 164,718,000 US dollars
- **Income before income taxes**: 2,445,380,000 US dollars
- **Income tax expense**: 544,495,000 US dollars
- **Net income**: 1,900,885,000 US dollars
- **U.S. Healthcare Solutions**: 215,193,522,000 US dollars
- **International Healthcare Solutions**: 22,421,335,000 US dollars
- **Litigation and opioid-related expenses, net**: 46,263,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Acquisition-related deal and integration expenses**: 190,930,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Restructuring and other expenses**: 140,390,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Depreciation**: 362,655,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Distribution, selling, and administrative**: 4,744,976,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
- **Revenue before reconciliation (calculated)**: 237,614,857,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Intersegment eliminations**: negative 10,592,000 US dollars. Reported reconciliation to consolidated revenue.
- **U.S. Healthcare Solutions costs (calculated)**: 212,491,235,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **International Healthcare Solutions costs (calculated)**: 21,923,719,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Reconciling items (calculated)**: 579,213,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to CENCORA, INC.: $1.89 B; to noncontrolling interests: $7.01 M.